Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Apyx Medical Corp (APYX) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Apyx Medical Corp. Table 2 shows the detailed insider transactions. This company's CIK number is 719135.
Total stock buying since 2005: $1,494,930.
Total stock sales since 2005: $3,113,838.
Total stock option exercises since 2005: $932,943.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 5,336 | $6,029 | 0 | $0 | 0 | $0 |
| 2023 | 52,500 | $83,975 | 15,000 | $113,400 | 30,338 | $70,303 |
| 2022 | 11,750 | $69,912 | 0 | $0 | 126,173 | $414,809 |
| 2021 | 0 | $0 | 0 | $0 | 13,063 | $36,707 |
| 2020 | 28,250 | $93,196 | 0 | $0 | 0 | $0 |
| 2016 | 90,750 | $299,475 | 0 | $0 | 0 | $0 |
| 2015 | 75,000 | $152,175 | 0 | $0 | 0 | $0 |
| 2014 | 0 | $0 | 0 | $0 | 37,500 | $79,875 |
| 2011 | 297,800 | $732,833 | 6,550 | $18,542 | 0 | $0 |
| 2010 | 0 | $0 | 30,006 | $96,385 | 0 | $0 |
| 2009 | 0 | $0 | 221,500 | $1,529,127 | 0 | $0 |
| 2008 | 2,000 | $12,020 | 40,000 | $288,468 | 50,000 | $112,500 |
| 2007 | 5,500 | $40,835 | 100,200 | $856,934 | 0 | $0 |
| 2006 | 0 | $0 | 15,000 | $45,753 | 180,000 | $179,374 |
| 2005 | 2,000 | $4,480 | 58,000 | $165,229 | 35,000 | $39,375 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-08 | 5,336 | $6,029 | 0 | $0 | 0 | $0 |
| 2023-12 | 2,500 | $5,475 | 0 | $0 | 0 | $0 |
| 2023-11 | 50,000 | $78,500 | 0 | $0 | 0 | $0 |
| 2023-07 | 0 | $0 | 0 | $0 | 5,338 | $15,853 |
| 2023-06 | 0 | $0 | 15,000 | $113,400 | 25,000 | $54,450 |
| 2022-08 | 11,750 | $69,912 | 0 | $0 | 0 | $0 |
| 2022-07 | 0 | $0 | 0 | $0 | 88,000 | $223,520 |
| 2022-05 | 0 | $0 | 0 | $0 | 14,000 | $39,060 |
| 2022-03 | 0 | $0 | 0 | $0 | 17,000 | $84,660 |
| 2022-01 | 0 | $0 | 0 | $0 | 7,173 | $67,569 |
| 2021-03 | 0 | $0 | 0 | $0 | 13,063 | $36,707 |
| 2020-05 | 28,250 | $93,196 | 0 | $0 | 0 | $0 |
| 2016-08 | 90,750 | $299,475 | 0 | $0 | 0 | $0 |
| 2015-12 | 55,000 | $104,375 | 0 | $0 | 0 | $0 |
| 2015-08 | 20,000 | $47,800 | 0 | $0 | 0 | $0 |
| 2014-09 | 0 | $0 | 0 | $0 | 37,500 | $79,875 |
| 2011-12 | 0 | $0 | 750 | $1,800 | 0 | $0 |
| 2011-08 | 147,800 | $347,333 | 0 | $0 | 0 | $0 |
| 2011-06 | 0 | $0 | 5,000 | $14,350 | 0 | $0 |
| 2011-05 | 0 | $0 | 800 | $2,392 | 0 | $0 |
| 2011-03 | 150,000 | $385,500 | 0 | $0 | 0 | $0 |
| 2010-12 | 0 | $0 | 28,256 | $88,135 | 0 | $0 |
| 2010-09 | 0 | $0 | 750 | $1,800 | 0 | $0 |
| 2010-03 | 0 | $0 | 1,000 | $6,450 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-08-13 | Hill Matthew C (Chief Financial Officer) | Buy | 5,336 | 1.13 | 6,029 |
| 2023-12-12 | Hill Matthew C (Chief Financial Officer) | Buy | 2,500 | 2.19 | 5,475 |
| 2023-11-14 | Goodwin Charles D. Ii (Chief Executive Officer) | Buy | 50,000 | 1.57 | 78,500 |
| 2023-07-12 | Waldman Lawrence | Option Ex | 5,338 | 2.97 | 15,853 |
| 2023-06-26 | Hornsby Todd (Executive Vice President) | Sale | 15,000 | 7.56 | 113,400 |
| 2023-06-26 | Hornsby Todd (Executive Vice President) | Option Ex | 15,000 | 1.77 | 26,550 |
| 2023-06-06 | Geraghty Michael (Director) | Option Ex | 10,000 | 2.79 | 27,900 |
| 2022-08-29 | Goodwin Charles D. Ii (Chief Executive Officer) | Buy | 11,750 | 5.95 | 69,912 |
| 2022-07-11 | Waldman Lawrence | Option Ex | 24,000 | 2.54 | 60,960 |
| 2022-07-11 | Citronowicz Moshe (Sr. V.P. of Operations) | Option Ex | 30,000 | 2.54 | 76,200 |
| 2022-07-06 | Geraghty Michael | Option Ex | 4,000 | 2.54 | 10,160 |
| 2022-07-05 | Makrides Andrew | Option Ex | 30,000 | 2.54 | 76,200 |
| 2022-05-19 | Waldman Lawrence | Option Ex | 8,000 | 2.79 | 22,320 |
| 2022-05-11 | Geraghty Michael | Option Ex | 6,000 | 2.79 | 16,740 |
| 2022-03-21 | Swandal Craig A. | Option Ex | 17,000 | 4.98 | 84,660 |
| 2022-01-07 | Swandal Craig A. | Option Ex | 7,173 | 9.42 | 67,569 |
| 2021-03-08 | Waldman Lawrence | Option Ex | 5,563 | 2.81 | 15,632 |
| 2021-03-05 | Geraghty Michael | Option Ex | 7,500 | 2.81 | 21,075 |
| 2020-05-13 | Goodwin Charles D. Ii (Chief Executive Officer) | Buy | 28,250 | 3.30 | 93,196 |
| 2016-08-17 | Mccarthy John J. Iii (Chief CommercializationOfficer) | Buy | 90,750 | 3.30 | 299,475 |
| 2015-12-22 | Mccarthy John J. Iii (Chief Commercialization Office) | Buy | 25,000 | 1.98 | 49,425 |
| 2015-12-21 | Gershon Robert (Chief Executive Officer) | Buy | 10,000 | 1.82 | 18,170 |
| 2015-12-21 | Citronowicz Moshe (Sr. V.P. of Operations) | Buy | 20,000 | 1.84 | 36,780 |
| 2015-08-01 | Gershon Robert (Chief Executive Officer) | Buy | 20,000 | 2.39 | 47,800 |
| 2014-09-19 | Saron J Robert (President) | Option Ex | 12,500 | 2.13 | 26,625 |
| 2014-09-19 | Makrides Andrew | Option Ex | 25,000 | 2.13 | 53,250 |
| 2011-12-23 | Konesky Gregory Alan (Director) | Sale | 750 | 2.40 | 1,800 |
| 2011-08-25 | Renn Universal Growth Investment Trust | Buy | 7,100 | 2.70 | 19,170 |
| 2011-08-24 | Renn Universal Growth Investment Trust | Buy | 14,100 | 2.66 | 37,534 |
| 2011-08-23 | Renn Universal Growth Investment Trust | Buy | 11,600 | 2.55 | 29,579 |
| 2011-08-09 | Renn Universal Growth Investment Trust | Buy | 115,000 | 2.27 | 261,050 |
| 2011-06-08 | Kromer George W (Director) | Sale | 5,000 | 2.87 | 14,350 |
| 2011-05-20 | Konesky Gregory Alan (Director) | Sale | 800 | 2.99 | 2,392 |
| 2011-03-07 | Renn Universal Growth Investment Trust | Buy | 150,000 | 2.57 | 385,500 |
| 2010-12-03 | Pardoll Peter (Director) | Sale | 6,078 | 3.08 | 18,720 |
| 2010-12-02 | Pardoll Peter (Director) | Sale | 17,478 | 3.10 | 54,094 |
| 2010-12-01 | Pardoll Peter (Director) | Sale | 4,700 | 3.26 | 15,321 |
| 2010-09-17 | Konesky Gregory Alan (Director) | Sale | 750 | 2.40 | 1,800 |
| 2010-03-29 | Konesky Gregory Alan (Director) | Sale | 1,000 | 6.45 | 6,450 |
| 2009-05-27 | Makrides Andrew (CEO) | Sale | 25,000 | 7.02 | 175,500 |
| 2009-05-26 | Makrides Andrew (CEO) | Sale | 32,500 | 7.10 | 230,750 |
| 2009-05-22 | Makrides Andrew (CEO) | Sale | 8,500 | 7.09 | 60,265 |
| 2009-05-21 | Makrides Andrew (CEO) | Sale | 39,000 | 7.20 | 280,800 |
| 2009-05-13 | Kromer George W (Director) | Sale | 9,000 | 7.14 | 64,260 |
| 2009-05-12 | Saron J Robert (Chief Sales & Mkt Officer) | Sale | 15,000 | 7.33 | 109,950 |
| 2009-05-12 | Citronowicz Moshe (Chief Operating Officer) | Sale | 13,500 | 7.45 | 100,575 |
| 2009-04-15 | Citronowicz Moshe (Chief Operating Officer) | Sale | 6,500 | 7.06 | 45,890 |
| 2009-04-09 | Citronowicz Moshe (Chief Operating Officer) | Sale | 21,000 | 6.34 | 133,140 |
| 2009-04-08 | Citronowicz Moshe (Chief Operating Officer) | Sale | 19,000 | 6.31 | 119,889 |
| 2009-04-07 | Saron J Robert (Chief Sales & Mkt Officer) | Sale | 13,500 | 6.34 | 85,590 |
| 2009-04-06 | Saron J Robert (Chief Sales & Mkt Officer) | Sale | 2,200 | 6.35 | 13,970 |
| 2009-04-03 | Saron J Robert (Chief Sales & Mkt Officer) | Sale | 4,100 | 6.31 | 25,871 |
| 2009-04-02 | Saron J Robert (Chief Sales & Mkt Officer) | Sale | 12,700 | 6.51 | 82,677 |
| 2008-09-19 | Citronowicz Moshe (Chief Operating Officer) | Sale | 21,700 | 7.23 | 156,891 |
| 2008-09-17 | Citronowicz Moshe (Chief Operating Officer) | Sale | 18,300 | 7.19 | 131,577 |
| 2008-06-17 | Rossi Randy D (Director) | Option Ex | 25,000 | 2.25 | 56,250 |
| 2008-06-12 | Rossi Randy D (Director) | Option Ex | 25,000 | 2.25 | 56,250 |
| 2008-02-15 | Madden Brian (Director) | Buy | 2,000 | 6.01 | 12,020 |
| 2007-08-23 | Rossi Randy D (Director) | Sale | 2,200 | 7.13 | 15,686 |
| 2007-05-23 | Rossi Randy D (Director) | Sale | 9,000 | 7.08 | 63,720 |
| 2007-05-21 | Madden Brian (Director) | Buy | 3,000 | 7.07 | 21,210 |
| 2007-05-08 | Rossi Randy D (Director) | Sale | 6,000 | 7.52 | 45,120 |
| 2007-03-06 | Madden Brian (Director) | Buy | 2,500 | 7.85 | 19,625 |
| 2007-02-13 | Citronowicz Moshe (Vice President of Operations) | Sale | 10,491 | 9.12 | 95,730 |
| 2007-02-09 | Citronowicz Moshe (Vice President of Operations) | Sale | 3,309 | 9.10 | 30,115 |
| 2007-02-08 | Citronowicz Moshe (Vice President of Operations) | Sale | 6,200 | 9.12 | 56,519 |
| 2007-01-25 | Saron J Robert (Vice President) | Sale | 11,300 | 8.72 | 98,524 |
| 2007-01-24 | Saron J Robert (Vice President) | Sale | 6,700 | 8.75 | 58,604 |
| 2007-01-19 | Kromer George W (Director) | Sale | 20,000 | 8.61 | 172,160 |
| 2007-01-12 | Makrides Andrew (President) | Sale | 10,600 | 8.71 | 92,294 |
| 2007-01-11 | Makrides Andrew (President) | Sale | 14,400 | 8.92 | 128,462 |
| 2006-11-29 | Saron J Robert (Vice President) | Option Ex | 30,000 | .75 | 22,500 |
| 2006-11-29 | Makrides Andrew (President and CEO) | Option Ex | 50,000 | 1.15 | 57,499 |
| 2006-11-29 | Kromer George W (Director) | Option Ex | 35,000 | .75 | 26,250 |
| 2006-02-27 | Saron J Robert (VP of Marketing) | Sale | 3,000 | 3.05 | 9,153 |
| 2006-02-24 | Saron J Robert (VP of Marketing) | Sale | 3,000 | 3.05 | 9,150 |
| 2006-02-23 | Saron J Robert (VP of Marketing) | Sale | 3,000 | 3.05 | 9,150 |
| 2006-02-22 | Saron J Robert (VP of Marketing) | Sale | 3,000 | 3.05 | 9,150 |
| 2006-02-21 | Saron J Robert (VP of Marketing) | Sale | 3,000 | 3.05 | 9,150 |
| 2006-02-15 | Saron J Robert (VP of Marketing) | Option Ex | 15,000 | 1.12 | 16,875 |
| 2006-01-18 | Kromer George W (Director) | Option Ex | 35,000 | 1.12 | 39,375 |
| 2006-01-06 | Saron J Robert (VP of Marketing) | Option Ex | 15,000 | 1.12 | 16,875 |
| 2005-12-21 | Citronowicz Moshe (Vice President of Op) | Sale | 15,000 | 2.86 | 42,900 |
| 2005-12-05 | Citronowicz Moshe (Vice President of Op) | Option Ex | 15,000 | 1.12 | 16,875 |
| 2005-12-02 | Peabody Charles (Other) | Sale | 30,000 | 2.87 | 85,950 |
| 2005-05-12 | Greco Alfred V (Director) | Sale | 3,000 | 2.26 | 6,779 |
| 2005-05-10 | Greco Alfred V (Director) | Buy | 2,000 | 2.24 | 4,480 |
| 2005-01-12 | Makrides Andrew (President and CEO) | Option Ex | 20,000 | 1.12 | 22,500 |
| 2005-01-06 | Citronowicz Moshe (Vice President of Op) | Sale | 10,000 | 2.96 | 29,600 |
Insider trading activities including stock purchases, stock sales, and option exercises of APYX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Apyx Medical Corp (symbol APYX, CIK number 719135) see the Securities and Exchange Commission (SEC) website.